Ventricular Assist Device in Children with Cardiac Graft Failure

Area of Science:

• Pediatric Cardiology
• Cardiovascular Surgery
• Transplantation Medicine

Background:

• Cardiac graft dysfunction is a significant challenge in pediatric heart transplantation.
• Ventricular assist devices (VADs) are used to support failing hearts.
• The efficacy of VADs in pediatric cardiac graft dysfunction requires further investigation.

Purpose of the Study:

• To evaluate the effectiveness of ventricular assist device (VAD) support in children experiencing cardiac graft dysfunction.
• To assess outcomes associated with short-term versus long-term VAD support in this pediatric population.

Main Methods:

• Retrospective review of VAD utilization at a single institution.
• Analysis of patient survival, recovery, and retransplantation rates.
• Identification of causes of mortality, particularly sepsis.

Main Results:

• Short-term VAD support demonstrated high success, bridging 89% of patients to recovery.
• Long-term VAD support had a lower survival rate to retransplant (29%).
• Sepsis, including fungal and bacterial infections, was a major cause of mortality in long-term VAD recipients.

Conclusions:

• Short-term VAD support is a viable strategy for pediatric cardiac graft dysfunction.
• The risk of infection, exacerbated by immunosuppression, significantly limits the long-term application of VADs in this cohort.
• Alternative or adjunctive strategies are needed to mitigate infectious complications for prolonged VAD support.